专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08394398B2 Methods of administering rapamycin analogs with anti-inflammatories using medical devices 失效
标题翻译：使用医疗器械用抗炎药管理雷帕霉素类似物的方法
公开(公告)号：US08394398B2
公开(公告)日：2013-03-12
申请号：US11548827
申请日：2006-10-12
申请人： John L. Toner , Sandra E. Burke , Keith R. Cromack , Matthew Mack
发明人： John L. Toner , Sandra E. Burke , Keith R. Cromack , Matthew Mack
IPC分类号： A01N43/42 , A61F2/06 , A61F13/00 , A61K31/44
CPC分类号： A61L31/16 , A61F2/91 , A61F2250/0067 , A61L2300/416 , A61L2300/45
摘要： A medical device comprising a supporting structure capable of including or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient may include one or more therapeutic agents or substances, with the carrier including a coating on the surface thereof, and the coating including the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. Drugs that are suitable for use in this invention include, but are not limited to, This drug can be used in combination with another drug including those selected from anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these drugs.
摘要翻译：一种医疗装置，其包括能够包含或支撑药学上可接受的载体或赋形剂的支持结构，所述载体或赋形剂可以包含一种或多种治疗剂或物质，所述载体在其表面上包括涂层，并且所述包衣包含治疗物质，例如药物。适用于本发明的医疗装置的支撑结构包括但不限于冠状支架，外周支架，导管，动静脉移植物，旁路移植物和用于脉管系统中的药物递送球囊。适用于本发明的药物包括但不限于：该药物可与另一药物组合使用，包括选自抗增殖剂，抗血小板剂，抗炎剂，抗血栓形成剂，细胞毒性药物，抑制细胞因子或趋化因子结合的药物，细胞去分化抑制剂，抗脂血症药，基质金属蛋白酶抑制剂，细胞抑制药物或这些药物的组合。

2. 发明授权

US08257726B2 Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices 有权
标题翻译：使用医疗器械对紫杉醇进行雷帕霉素类似物的组合物，系统，试剂盒和方法
公开(公告)号：US08257726B2
公开(公告)日：2012-09-04
申请号：US11464667
申请日：2006-08-15
申请人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
发明人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
IPC分类号： A61F2/00 , A61K31/44 , A61K31/335
CPC分类号： A61K31/337 , A61K31/4745 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L31/10 , A61L31/16 , A61L2300/416 , A61M31/002
摘要： A system and compositions including zotarolimus and paclitaxel are disclosed, as well as methods of delivery, wherein the drugs have effects that complement each other. Medical devices are disclosed which include supporting structures that include at least one pharmaceutically acceptable carrier or excipient, which carrier or excipient can include one or more therapeutic agents or substances, with the carrier including at least one coating on the surface thereof, and the coating associated with the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
摘要翻译：公开了包含唑他罗莫司和紫杉醇的系统和组合物，以及递送方法，其中药物具有彼此补充的效果。公开了包括至少一种药学上可接受的载体或赋形剂的载体结构的医疗装置，该载体或赋形剂可以包括一种或多种治疗剂或物质，载体包括其表面上的至少一层，并且涂层相关与治疗物质，例如药物。适用于本发明的医疗装置的支撑结构包括但不限于冠状支架，外周支架，导管，动静脉移植物，旁路移植物和用于脉管系统中的药物递送球囊。这些组合物和系统可以与其它药物组合使用，包括抗增殖剂，抗血小板剂，抗炎剂，抗血栓形成剂，细胞毒性药物，抑制细胞因子或趋化因子结合的药物，细胞去分化抑制剂，抗脂血症药，基质金属蛋白酶抑制剂，细胞抑制药物或这些和其他药物的组合。

3. 发明申请

US20090162413A1 COMPOSITIONS AND METHODS OF ADMINISTERING RAPAMYCIN ANALOGS WITH PACLITAXEL USING MEDICAL DEVICES 审中-公开
标题翻译：使用医疗器械管理吡虫啉类似物的组合物和方法
公开(公告)号：US20090162413A1
公开(公告)日：2009-06-25
申请号：US12090253
申请日：2006-10-12
申请人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
发明人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
IPC分类号： A61K9/00 , A61K31/337 , A61K31/395 , A61K31/56 , A61P7/02
CPC分类号： C07D498/18 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L31/10 , A61L31/16 , A61L2300/254 , A61L2300/40 , A61L2300/41 , A61L2300/416 , A61L2300/42 , A61L2300/43 , A61L2300/45 , A61L2300/606
摘要： Systems and compositions comprising paclitaxel and a second drug, such as rapamycin, analogs, derivatives, salts and esters thereof are disclosed, as well as methods of delivery wherein the drugs have effects that complement each other. Medical devices comprising supporting structures capable of including or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient can contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating including the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
摘要翻译：公开了包含紫杉醇和第二药物如雷帕霉素，类似物，衍生物，盐和酯的系统和组合物，以及其中药物具有互补作用的递送方法。包含能够包含或支持药学上可接受的载体或赋形剂的支持结构的医疗装置，所述载体或赋形剂可以含有一种或多种治疗剂或物质，所述载体优选在其表面上包括涂层，所述包衣包括治疗物质，例如药物。适用于本发明的医疗装置的支撑结构包括冠状支架，外周支架，导管，动静脉移植物，旁路移植物和用于脉管系统中的药物递送球囊。这些组合物和系统可以与其它药物组合使用，包括抗增殖剂，抗血小板剂，抗炎剂，抗血栓形成剂，细胞毒性药物，抑制细胞因子或趋化因子结合的药物，细胞去分化抑制剂，抗脂血症药，基质金属蛋白酶抑制剂，细胞抑制药物或这些和其他药物的组合。

4. 发明申请

US20090060970A1 Compositions and methods of administering paclitaxel with other drugs using medical devices 有权
标题翻译：使用医疗器械给予紫杉醇与其他药物的组合物和方法
公开(公告)号：US20090060970A1
公开(公告)日：2009-03-05
申请号：US11548974
申请日：2006-10-12
申请人： John L. Toner , Sandra E. Burke , Keith R. Cromack , Matthew Mack
发明人： John L. Toner , Sandra E. Burke , Keith R. Cromack , Matthew Mack
IPC分类号： A61K31/337 , A61K31/436 , A61K31/573 , A61K31/565 , A61K39/395 , A61K31/704 , A61K31/727 , A61K38/49 , A61K38/48 , A61F2/02
CPC分类号： A61K31/337 , A61K9/0024 , A61K31/436 , A61L31/10 , A61L31/16 , A61L2300/416 , A61L2300/45 , C07D498/18
摘要： Systems and compositions comprising paclitaxel and a second drug, such as rapamycin, analogs, derivatives, salts and esters thereof are disclosed, as well as methods of delivery wherein the drugs have effects that complement each other. Medical devices comprising supporting structures capable of including or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient can contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating including the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
摘要翻译：公开了包含紫杉醇和第二药物如雷帕霉素，类似物，衍生物，盐和酯的系统和组合物，以及其中药物具有互补作用的递送方法。包含能够包含或支持药学上可接受的载体或赋形剂的支持结构的医疗装置，所述载体或赋形剂可以含有一种或多种治疗剂或物质，所述载体优选在其表面上包括涂层，所述包衣包括治疗物质，例如药物。适用于本发明的医疗装置的支撑结构包括冠状支架，外周支架，导管，动静脉移植物，旁路移植物和用于脉管系统中的药物递送球囊。这些组合物和系统可以与其它药物组合使用，包括抗增殖剂，抗血小板剂，抗炎剂，抗血栓形成剂，细胞毒性药物，抑制细胞因子或趋化因子结合的药物，细胞去分化抑制剂，抗脂血症药，基质金属蛋白酶抑制剂，细胞抑制药物或这些和其他药物的组合。

5. 发明授权

US08318190B2 Method of treating disorders using compositions comprising zotarolimus and paclitaxel 有权
标题翻译：使用包含佐他莫司和紫杉醇的组合物治疗病症的方法
公开(公告)号：US08318190B2
公开(公告)日：2012-11-27
申请号：US12034612
申请日：2008-02-20
申请人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
发明人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
IPC分类号： A61F2/00 , A61K31/44 , A61K31/335
CPC分类号： A61K31/337 , A61K31/4745 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L31/10 , A61L31/16 , A61L2300/416 , A61M31/002
摘要： A system and compositions including zotarolimus and paclitaxel are disclosed, as well as methods of delivery, wherein the drugs have effects that complement each other. Medical devices are disclosed which include supporting structures that include at least one pharmaceutically acceptable carrier or excipient, which carrier or excipient can include one or more therapeutic agents or substances, with the carrier including at least one coating on the surface thereof, and the coating associated with the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
摘要翻译：公开了包含唑他罗莫司和紫杉醇的系统和组合物，以及递送方法，其中药物具有彼此补充的效果。公开了包括至少一种药学上可接受的载体或赋形剂的载体结构的医疗装置，该载体或赋形剂可以包括一种或多种治疗剂或物质，载体包括其表面上的至少一层，并且涂层相关与治疗物质，例如药物。适用于本发明的医疗装置的支撑结构包括但不限于冠状支架，外周支架，导管，动静脉移植物，旁路移植物和用于脉管系统中的药物递送球囊。这些组合物和系统可以与其它药物组合使用，包括抗增殖剂，抗血小板剂，抗炎剂，抗血栓形成剂，细胞毒性药物，抑制细胞因子或趋化因子结合的药物，细胞去分化抑制剂，抗脂血症药，基质金属蛋白酶抑制剂，细胞抑制药物或这些和其他药物的组合。

6. 发明授权

US07357942B2 Compositions, systems, and kits for administering zotarolimus and paclitaxel to blood vessel lumens 有权
标题翻译：组合物，系统和用于给予血管内膜的佐他莫司和紫杉醇的试剂盒
公开(公告)号：US07357942B2
公开(公告)日：2008-04-15
申请号：US11464676
申请日：2006-08-15
申请人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
发明人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
IPC分类号： A61F2/02 , A61K31/44 , A61K31/335
CPC分类号： A61K31/337 , A61K31/4745 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L31/10 , A61L31/16 , A61L2300/416 , A61M31/002
摘要： A system and compositions including zotarolimus and paclitaxel are disclosed, as well as methods of delivery, wherein the drugs have effects that complement each other. Medical devices are disclosed which include supporting structures that include at least one pharmaceutically acceptable carrier or excipient, which carrier or excipient can include one or more therapeutic agents or substances, with the carrier including at least one coating on the surface thereof, and the coating associated with the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
摘要翻译：公开了包含唑他罗莫司和紫杉醇的系统和组合物，以及递送方法，其中药物具有彼此补充的效果。公开了包括至少一种药学上可接受的载体或赋形剂的载体结构的医疗装置，该载体或赋形剂可以包括一种或多种治疗剂或物质，载体包括其表面上的至少一层，并且涂层相关与治疗物质，例如药物。适用于本发明的医疗装置的支撑结构包括但不限于冠状支架，外周支架，导管，动静脉移植物，旁路移植物和用于脉管系统中的药物递送球囊。这些组合物和系统可以与其它药物组合使用，包括抗增殖剂，抗血小板剂，抗炎剂，抗血栓形成剂，细胞毒性药物，抑制细胞因子或趋化因子结合的药物，细胞去分化抑制剂，抗脂血症药，基质金属蛋白酶抑制剂，细胞抑制药物或这些和其他药物的组合。

7. 发明授权

US08057816B2 Compositions and methods of administering paclitaxel with other drugs using medical devices 有权
标题翻译：使用医疗器械给予紫杉醇与其他药物的组合物和方法
公开(公告)号：US08057816B2
公开(公告)日：2011-11-15
申请号：US11548974
申请日：2006-10-12
申请人： John L. Toner , Sandra E. Burke , Keith R. Cromack , Matthew Mack
发明人： John L. Toner , Sandra E. Burke , Keith R. Cromack , Matthew Mack
IPC分类号： A61F2/00 , A01N63/00 , A01N43/42 , A01N43/04 , A61K39/395 , A61K31/44 , A61K31/56 , A61K31/727 , A61K31/355
CPC分类号： A61K31/337 , A61K9/0024 , A61K31/436 , A61L31/10 , A61L31/16 , A61L2300/416 , A61L2300/45 , C07D498/18
摘要： Systems and compositions comprising paclitaxel and a second drug, such as rapamycin, analogs, derivatives, salts and esters thereof are disclosed, as well as methods of delivery wherein the drugs have effects that complement each other. Medical devices comprising supporting structures capable of including or supporting a pharmaceutically acceptable carrier or excipient, which carrier or excipient can contain one or more therapeutic agents or substances, with the carrier preferably including a coating on the surface thereof, and the coating including the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
摘要翻译：公开了包含紫杉醇和第二药物如雷帕霉素，类似物，衍生物，盐和酯的系统和组合物，以及其中药物具有互补作用的递送方法。包含能够包含或支持药学上可接受的载体或赋形剂的支持结构的医疗装置，所述载体或赋形剂可以含有一种或多种治疗剂或物质，所述载体优选在其表面上包括涂层，所述包衣包含治疗物质，例如药物。适用于本发明的医疗装置的支撑结构包括冠状支架，外周支架，导管，动静脉移植物，旁路移植物和用于脉管系统中的药物递送球囊。这些组合物和系统可以与其它药物组合使用，包括抗增殖剂，抗血小板剂，抗炎剂，抗血栓形成剂，细胞毒性药物，抑制细胞因子或趋化因子结合的药物，细胞去分化抑制剂，抗脂血症药，基质金属蛋白酶抑制剂，细胞抑制药物或这些和其他药物的组合。

8. 发明申请

US20080213278A1 Method Of Treating Disorders Using Compositions Comprising Zotarolimus And Paclitaxel 有权
标题翻译：使用佐他莫司和紫杉醇组合治疗疾病的方法
公开(公告)号：US20080213278A1
公开(公告)日：2008-09-04
申请号：US12034612
申请日：2008-02-20
申请人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
发明人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
IPC分类号： A61K39/395 , A61K31/4353 , A61P35/00 , A61P37/00 , A61K31/56
CPC分类号： A61K31/337 , A61K31/4745 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L31/10 , A61L31/16 , A61L2300/416 , A61M31/002
摘要： A system and compositions including zotarolimus and paclitaxel are disclosed, as well as methods of delivery, wherein the drugs have effects that complement each other. Medical devices are disclosed which include supporting structures that include at least one pharmaceutically acceptable carrier or excipient, which carrier or excipient can include one or more therapeutic agents or substances, with the carrier including at least one coating on the surface thereof, and the coating associated with the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
摘要翻译：公开了包含唑他罗莫司和紫杉醇的系统和组合物，以及递送方法，其中药物具有彼此补充的效果。公开了包括至少一种药学上可接受的载体或赋形剂的载体结构的医疗装置，该载体或赋形剂可以包括一种或多种治疗剂或物质，载体包括其表面上的至少一层，并且涂层相关与治疗物质，例如药物。适用于本发明的医疗装置的支撑结构包括但不限于冠状支架，外周支架，导管，动静脉移植物，旁路移植物和用于脉管系统中的药物递送球囊。这些组合物和系统可以与其它药物组合使用，包括抗增殖剂，抗血小板剂，抗炎剂，抗血栓形成剂，细胞毒性药物，抑制细胞因子或趋化因子结合的药物，细胞去分化抑制剂，抗脂血症药，基质金属蛋白酶抑制剂，细胞抑制药物或这些和其他药物的组合。

9. 发明授权

US07378105B2 Drug delivery systems, kits, and methods for administering zotarolimus and paclitaxel to blood vessel lumens 有权
标题翻译：药物输送系统，试剂盒和将唑妥洛莫司和紫杉醇施用于血管腔的方法
公开(公告)号：US07378105B2
公开(公告)日：2008-05-27
申请号：US11464659
申请日：2006-08-15
申请人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
发明人： Sandra E. Burke , Keith R. Cromack , Matthew Mack , John L. Toner
IPC分类号： A61F2/00 , A61K31/44
CPC分类号： A61K31/337 , A61K31/4745 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L31/10 , A61L31/16 , A61L2300/416 , A61M31/002
摘要： A system and compositions including zotarolimus and paclitaxel are disclosed, as well as methods of delivery, wherein the drugs have effects that complement each other. Medical devices are disclosed which include supporting structures that include at least one pharmaceutically acceptable carrier or excipient, which carrier or excipient can include one or more therapeutic agents or substances, with the carrier including at least one coating on the surface thereof, and the coating associated with the therapeutic substances, such as, for example, drugs. Supporting structures for the medical devices that are suitable for use in this invention include, but are not limited to, coronary stents, peripheral stents, catheters, arterio-venous grafts, by-pass grafts, and drug delivery balloons used in the vasculature. These compositions and systems can be used in combination with other drugs, including anti-proliferative agents, anti-platelet agents, anti-inflammatory agents, anti-thrombotic agents, cytotoxic drugs, agents that inhibit cytokine or chemokine binding, cell de-differentiation inhibitors, anti-lipaedemic agents, matrix metalloproteinase inhibitors, cytostatic drugs, or combinations of these and other drugs.
摘要翻译：公开了包含唑他罗莫司和紫杉醇的系统和组合物，以及递送方法，其中药物具有彼此补充的效果。公开了包括至少一种药学上可接受的载体或赋形剂的载体结构的医疗装置，该载体或赋形剂可以包括一种或多种治疗剂或物质，载体包括其表面上的至少一层，并且涂层相关与治疗物质，例如药物。适用于本发明的医疗装置的支撑结构包括但不限于冠状支架，外周支架，导管，动静脉移植物，旁路移植物和用于脉管系统中的药物递送球囊。这些组合物和系统可以与其它药物组合使用，包括抗增殖剂，抗血小板剂，抗炎剂，抗血栓形成剂，细胞毒性药物，抑制细胞因子或趋化因子结合的药物，细胞去分化抑制剂，抗脂血症药，基质金属蛋白酶抑制剂，细胞抑制药物或这些和其他药物的组合。

10. 发明授权

US08257725B2 Delivery of highly lipophilic agents via medical devices 有权
公开(公告)号：US08257725B2
公开(公告)日：2012-09-04
申请号：US11386498
申请日：2006-03-22
申请人： Keith R. Cromack , John L. Toner , Sandra E. Burke , Richard W. Krasula , Lewis B. Schwartz
发明人： Keith R. Cromack , John L. Toner , Sandra E. Burke , Richard W. Krasula , Lewis B. Schwartz
IPC分类号： A61F2/00
CPC分类号： A61L31/16 , A61L15/44 , A61L27/34 , A61L27/54 , A61L29/085 , A61L29/16 , A61L31/10 , A61L2300/22 , A61L2300/416 , A61L2300/45
摘要： An apparatus and system for delivering a lipophilic agent associated with a medical device including: a medical device, a first lipophilic agent capable of penetrating a body lumen, wherein the transfer coefficients of the first lipophilic agent is by an amount that is statistically significant of at least approximately 5,000, wherein the first lipophilic agent is associated with the medical device, wherein the first lipophilic agent/medical device is placed adjacent to said body lumen, and wherein a therapeutically effective amount of the first lipophilic agent is delivered to a desired area within a subject. Furthermore, the invention relates to a method for improving patency in a subject involving placement of a medical device in a body lumen for treating and/or preventing adjacent diseases or maintaining patency of the body lumen.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式